201 related articles for article (PubMed ID: 20876747)
1. Phenyl ring-substituted lobelane analogs: inhibition of [³H]dopamine uptake at the vesicular monoamine transporter-2.
Nickell JR; Zheng G; Deaciuc AG; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2011 Mar; 336(3):724-33. PubMed ID: 20876747
[TBL] [Abstract][Full Text] [Related]
2. Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
Horton DB; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2011 Oct; 339(1):286-97. PubMed ID: 21778282
[TBL] [Abstract][Full Text] [Related]
3. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
[TBL] [Abstract][Full Text] [Related]
4. The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.
Nickell JR; Siripurapu KB; Vartak A; Crooks PA; Dwoskin LP
Adv Pharmacol; 2014; 69():71-106. PubMed ID: 24484975
[TBL] [Abstract][Full Text] [Related]
5. Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.
Zheng G; Dwoskin LP; Deaciuc AG; Norrholm SD; Crooks PA
J Med Chem; 2005 Aug; 48(17):5551-60. PubMed ID: 16107155
[TBL] [Abstract][Full Text] [Related]
6. GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine.
Horton DB; Nickell JR; Zheng G; Crooks PA; Dwoskin LP
J Neurochem; 2013 Oct; 127(2):177-86. PubMed ID: 23875622
[TBL] [Abstract][Full Text] [Related]
7. New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
Lee NR; Zheng G; Crooks PA; Bardo MT; Dwoskin LP
AAPS J; 2018 Feb; 20(2):29. PubMed ID: 29427069
[TBL] [Abstract][Full Text] [Related]
8. meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
Horton DB; Siripurapu KB; Norrholm SD; Culver JP; Hojahmat M; Beckmann JS; Harrod SB; Deaciuc AG; Bardo MT; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2011 Mar; 336(3):940-51. PubMed ID: 21177475
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolidine analogs of GZ-793A: synthesis and evaluation as inhibitors of the vesicular monoamine transporter-2 (VMAT2).
Penthala NR; Ponugoti PR; Nickell JR; Deaciuc AG; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2013 Jun; 23(11):3342-5. PubMed ID: 23597792
[TBL] [Abstract][Full Text] [Related]
10. 1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2.
Nickell JR; Culver JP; Janganati V; Zheng G; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2016 Jul; 26(13):2997-3000. PubMed ID: 27212067
[TBL] [Abstract][Full Text] [Related]
11. GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2.
Nickell JR; Siripurapu KB; Horton DB; Zheng G; Crooks PA; Dwoskin LP
Eur J Pharmacol; 2017 Jan; 795():143-149. PubMed ID: 27986625
[TBL] [Abstract][Full Text] [Related]
12. Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
Joolakanti SR; Nickell JR; Janganati V; Zheng G; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2016 May; 26(10):2422-2427. PubMed ID: 27080180
[TBL] [Abstract][Full Text] [Related]
13. The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
Beckmann JS; Siripurapu KB; Nickell JR; Horton DB; Denehy ED; Vartak A; Crooks PA; Dwoskin LP; Bardo MT
J Pharmacol Exp Ther; 2010 Dec; 335(3):841-51. PubMed ID: 20805303
[TBL] [Abstract][Full Text] [Related]
14. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
Lee NR; Zheng G; Leggas M; Janganati V; Nickell JR; Crooks PA; Bardo MT; Dwoskin LP
J Pharmacol Exp Ther; 2019 Nov; 371(2):526-543. PubMed ID: 31413138
[TBL] [Abstract][Full Text] [Related]
15. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptake.
Ding D; Nickell JR; Deaciuc AG; Penthala NR; Dwoskin LP; Crooks PA
Bioorg Med Chem; 2013 Nov; 21(21):6771-7. PubMed ID: 23993667
[TBL] [Abstract][Full Text] [Related]
17. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
Meyer AC; Neugebauer NM; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
J Neurochem; 2013 Oct; 127(2):187-98. PubMed ID: 23875705
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2).
Vartak AP; Nickell JR; Chagkutip J; Dwoskin LP; Crooks PA
J Med Chem; 2009 Dec; 52(23):7878-82. PubMed ID: 19691331
[TBL] [Abstract][Full Text] [Related]
19. Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
Ding D; Nickell JR; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2015 Jul; 25(13):2613-6. PubMed ID: 25991431
[TBL] [Abstract][Full Text] [Related]
20. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
Teng L; Crooks PA; Dwoskin LP
J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
